Facebook
Twitter
LinkedIn
ForwardHematology & Medical Oncology Practice Updates and Board Review 2025 - Live (in-person)
Course Director: Kebede H. Begna, M.D.
Co-Directors: Tanios S. Bekaii-Saab, M.D., Naseema Gangat, M.B.B.S., Wilson I. Gonsalves, M.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., Sameer A. Parikh, M.B.B.S., and Kathryn J. Ruddy, M.D.
February 3 - 7, 2025 - The Ritz Carlton Maui - Kapalua, Hawaii
The Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review course is designed to provide attendees with up-to-date, practical information and best practices that can be applied immediately into daily clinical practice. In addition, the high-yield program content prepares candidates for the American Board of Internal Medicine (ABIM) initial and maintenance of certification examinations in hematology and medical oncology.
Course Highlights:
- Comprehensive, high-yield review led by Mayo Clinic experts
- Updates on latest guidelines and practices in the field
- Dedicated time for questions and discussion
- Daily optional practice sessions in board review format
- Access to course recordings for one year
Target Audience
This course is designed for hematologists, oncologists, internal medicine physicians, NPs, PAs and other internists with interest in hematology and medical oncology. Others that may find this course beneficial include physicians needing MOC and those preparing for certification or recertification in hematology and medical oncology.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Utilize evidence-based practice to manage patients with bleeding and/or clotting disorders
- Choose appropriate molecular tests like next generation sequencing for cancer diagnosis
- Integrate into practice the most current treatment options like immuno- or targeted-therapy for cancers
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Schedule reflects Hawaii time zone.
PDF/Printable Version
MONDAY, February 3 | |
5:45 a.m. – 7:00 a.m. | Registration, Breakfast & Exhibits |
6:00 a.m. | Optional Breakfast Learning Session Board Review Style Questions – Breast and GI (pre-test) Brenda Ernst, M.D. Thor Halfdanarson, M.D. |
7:00 a.m. | Welcome Announcements – General Session
|
Breast Cancer Moderator: Kathryn Ruddy, M.D. | |
7:05 a.m.
| Early Breast Cancer – Locoregional Therapy (including surgery & radiotherapy) Tina Hieken, M.D. |
7:25 a.m. | Systemic Therapy for Her2- Positive Breast Cancer: Curative & Palliative Pooja Advani, M.B.B.S., M.D. |
8:00 a.m.
| Systemic Therapy for Triple Negative Breast Cancer: Curative & Palliative Roberto Leon Ferre, M.D. |
8:35 a.m.
| Systemic Therapy for ER+Her2- Breast Cancer: Curative & Palliative Tufia Haddad, M.D. |
9:10 a.m. | Panel Question and Answer Session
|
9:30 a.m. | Refreshment Break & Exhibits
|
Gastrointestinal Cancer Moderators: Tanios Bekaii-Saab, M.D. and Thor Halfdanarson, M.D. | |
9:45 a.m.
| Management of Early-stage Colorectal Cancer Including Non-Operative Management of Rectal Cancer Jeremy Jones, M.D. |
10:15 a.m.
| Management of Advanced Colorectal Cancer Tanios Bekaii-Saab, M.D. |
10:45 a.m.
| Upper GI & other GI Cancers Bassam Sonbol, M.D. |
11:15 a.m.
| Management of Hepatobiliary Cancers Mitesh Borad, M.D. |
11:45 a.m.
| Management of Pancreatic Cancer Robert McWilliams, M.D. |
12:15 p.m.
| Panel Question and Answer Session
|
12:35 p.m. | Adjourn
|
TUESDAY, February 4 | |
5:45 a.m. – 7:00 a.m. | Breakfast & Exhibits |
6:00 a.m.
| Optional Breakfast Learning Session Board Review Style Questions – Lung, Head and Neck and Neuro / GU Cancers and Sarcoma Rami Manochakian, M.D. Dan Childs, M.D. |
7:00 a.m. | Welcome Announcements – General Session
|
Lung, other Thoracic, Head & Neck Cancer, Neuro-Oncology Moderator: Rami Manochakian, M.D. | |
7:05 a.m.
| Early Stage NSCLC Vinicius Ernani, M.D. |
7:35 a.m.
| Advanced Stage NSCLC Rami Manochakian, M.D. |
8:10 a.m.
| Small Cell Lung Cancer Kaushal Parikh, M.B.B.S. |
8:35 a.m.
| Other Thoracic Malignancies (mesothelioma, thymic, neuroendocrine) Kostas Leventakos, M.D., Ph.D. |
9:00 a.m.
| Panel Question and Answer Session
|
9:10 a.m. | Refreshment Break & Exhibits
|
9:20 a.m.
| Head and Neck Cancer Katharine Price, M.D. Daniel Price, M.D. |
9:50 a.m.
| Neuro-Oncology Alyx Porter, M.D. |
10:10 a.m.
| Sarcoma Steve Robinson, M.B.B.S. |
10:30 a.m.
| Panel Question and Answer Session
|
10:40 a.m. | Refreshment Break & Exhibits
|
Genitourinary Cancer Moderator: Thor Halfdanarson, M.D. | |
10:50 a.m.
| Bladder / Urothelial Cancer Parminder Singh, M.D. |
11:20 a.m.
| Renal Cell Carcinoma Yousef Zakharia |
11:50 a.m.
| Germ Cell Cancers Lance Pagliaro, M.D. |
12:10 a.m.
| Prostate Cancer Dan Childs, M.D. |
12:45 p.m.
| Panel Question and Answer Session
|
12:55 p.m. | Adjourn
|
WEDNESDAY, February 5 | |
5:45 a.m. – 7:00 a.m. | Breakfast & Exhibits |
6:00 a.m.
| Optional Breakfast Learning Session Board Review Style Questions – Gyn & Other Cancers / Miscellaneous Andrea Wahner-Hendrickson, M.D. Ryan Carr, M.D., Ph.D. |
7:00 a.m. | Welcome Announcements – General Session
|
Gynecologic and Other Cancers Moderator: Kathryn Ruddy, M.D. | |
7:05 a.m.
| Ovarian Cancer Andrea Wahner-Hendrickson, M.D. |
7:45 a.m.
| Cancers of the Cervix, Uterus and Other Less Common GYN Cancers John Weroha, M.D., Ph.D. |
8:20 a.m.
| Melanoma Svetomir Markovic, M.D., Ph.D. |
8:45 a.m.
| Endocrine Oncology (thyroid, adrenals) Mabel Ryder, M.D. |
9:10 a.m.
| Panel Question and Answer Session
|
9:20 a.m. | Refreshment Break & Exhibits
|
Miscellaneous Moderators: Kebede Begna, M.D. and Thor Halfdanrson, M.D. | |
9:30 a.m.
| Genomics for Hematologist/Medical Oncologist Ryan Carr, M.D., Ph.D. |
10:00 a.m.
| Hereditary Syndromes (when to refer to clinical genomics, germline testing, etc.) Siddhartha Yadav, M.B.B.S., M.D. |
10:25 a.m.
| Transfusion Medicine for Hematologist/Medical Oncologist Jeffrey Winters, M.D. |
10:50 a.m.
| Panel Question and Answer Session
|
11:00 a.m. | Refreshment Break & Exhibits
|
11:10 a.m.
| Management of Thrombosis in Cancer Aneel Ashrani, M.D., M.S. |
11:35 a.m.
| Palliative Care and Symptom Management Jacob Strand, M.D. |
12:00 p.m.
| Cancer Survivorship: Crafting a Blueprint for the Future of Assessing/Managing Complications, cardio-, neuro-, renal- toxicity, etc. Carrie Thompson, M.D. |
12:25 p.m.
| Panel Question and Answer Session
|
12:35 p.m. | Adjourn
|
THURSDAY, February 6 | |
5:45 a.m. – 7:00 a.m. | Breakfast & Exhibits |
6:00 a.m.
| Optional Breakfast Learning Session Board Review Style Questions – Lymphoid Malignancies / Dysproteinemia Jonas Paludo, M.D. Ricardo Parrondo, M.D. Muhamad Alhaj-Moustafa, M.D., M.S. Erin Wiedmeier-Nutor, M.D., M.P.H. |
7:00 a.m. | Welcome Announcements – General Session
|
Lymphoid Malignancies Moderators: Sameer Parikh, M.B.B.S. | |
7:05 a.m.
| Hodgkin Lymphoma Stephen Ansell, M.D., Ph.D. |
7:25 a.m.
| Aggressive B Cell Lymphoma Grzegorz Nowakowski, M.D. |
7:50 a.m.
| CLL Sameer Parikh, M.B.B.S. |
8:15 a.m.
| Follicular Lymphoma and Mantle Cell Lymphoma Thomas Witzig, M.D. |
8:40 a.m.
| Other Indolent non-Hodgkin Lymphoma Thomas Habermann, M.D. |
9:05 a.m.
| T Cell Lymphoma Allison Rosenthal, D.O. |
9:25 a.m.
| Panel Question and Answer Session
|
9:40 a.m. | Refreshment Break & Exhibits
|
Dysproteinemia Moderator: Wilson Gonsalves, M.D. | |
9:55 a.m.
| MGUS / Smoldering Myeloma Angela Dispenzieri, M.D. |
10:20 a.m.
| Newly Diagnosed Multiple Myeloma Vivek Roy, M.D. |
10:50 a.m.
| Relapsed / Refractory Multiple Myeloma Rafael Fonseca, M.D. |
11:20 a.m.
| Cellular Therapy for Hematological Malignancies Yi Lin, M.D., Ph.D. |
11:50 a.m.
| Waldenstrom Macroglobulinemia and Amyloidosis Morie Gertz, M.D. |
12:15 p.m.
| Panel Question and Answer Session
|
12:30 p.m. | Adjourn
|
FRIDAY, February 7 | ||
5:45 a.m. – 7:00 a.m. | Breakfast & Exhibits | |
6:00 a.m.
| Optional Breakfast Learning Session Board Review Style Questions – Myeloid Neoplasms / Classic Hematology Lisa Sproat, M.D. Meera Sridharan, M.D., Ph.D. Abhishek Mangaonkar, M.B.B.S. Surbhi Shah, M.B.B.S. | |
7:00 a.m. | Welcome Announcements – General Session
| |
Myeloid Neoplasms Moderators: Kebede Begna, M.D. and Naseema Gangat, M.B.B.S. | ||
7:05 a.m.
| MPN and CML Ayalew Tefferi, M.D. | |
7:35 a.m.
| BMF Syndromes: CCUS/ICUS/MDS/AA Mrinal Patnaik, M.B.B.S. | |
8:05 a.m.
| Mast Cell & Eosinophilic Neoplasms Animesh Pardanani, M.B.B.S., M.D. | |
8:25 a.m.
| Acute Myeloid Leukemia Naseema Gangat, M.B.B.S. | |
8:55 a.m.
| Acute Lymphoblastic Leukemia Mark Litzow, M.D. | |
9:25 a.m.
| Transplantation for Hematological Disorders including GVHD William Hogan, M.B., B.Ch. | |
9:55 a.m.
| Panel Question and Answer Session
| |
10:05 a.m. | Refreshment Break & Exhibits
| |
Consultative & Classical Hematology Moderators: Ronald Go, M.D. and Surbhi Shah, M.B.B.S. | ||
10:15 a.m.
| Thrombotic Microangiopathy / HLH & Porphyrias Alexandra Wolanskyi-Spinner, M.D. | |
10:40 a.m.
| Platelet & Megakaryocyte Disorders Meera Sridharan, M.D., Ph.D. | |
11:05 a.m.
| Coagulation Factors Disorder: Molecular Basis, Inherited and Acquired Bleeding Disorders Rajiv Pruthi, M.B.B.S. | |
11:25 a.m.
| Sickle Cell Disease, Thalassemia & Other Hemoglobinopathies Ewa Wysokinska, M.D. | |
11:50 a.m.
| Anemia / Iron Metabolism Disorders Ronald Go, M.D. |
|
12:15 p.m.
| Hemolytic Anemias including PNH Surbhi Shah, M.B.B.S. |
|
12:40 p.m.
| Panel Question and Answer Session
| |
12:50 p.m. | Adjourn
| |
Lodging
Rooms have been reserved for attendees and their guests at the Ritz Carlton for discounted rates starting at $449/night. In order to receive the special rates, reservations must be made before January 6, 2025, or before the room block fills.
Room reservations after are based on space and rate availability. Additional taxes will apply. Valet and self-parking options are available for additional fees.
- Deluxe resort view: $449/night
- Deluxe ocean view: $489/night
Click here to make reservation online (select resort or ocean view) or call 800-262-8440 and identify yourself as a participant of the 2025 Hematology/Oncology Board Review when making reservations.
Daily Resort Fee ($20):
The daily resort fee $40 is discounted at a rate of $20 per room per night for all attendees staying at the resort. The fee includes the following:
- Enhanced high-speed guest room Wi-Fi
- Kapalua Resort Shuttle Services (travel within Kapalua Resort)
- Aloha welcome experience with non-alcoholic beverage delighter and fresh flower or kukui nut lei
- Discounted golf fees & preferred tee times at Kapalua Plantation & Bay courses
- 24-hour fitness center access
- in-room coffee & complimentary bottled water
- Resort activities (basketball, tennis & pickleball, shuffleboard, croquet)
- Signature daily experiences including guided labyrinth mediation walk, sunrise yoga, etc. (offerings change seasonally)
Travel
All travel and lodging expenses are the sole responsibility of the individual registrant. Mayo Clinic School of Continuous Professional Development is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registration such as airline or hotel fees or penalties are the responsibility of the registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 31.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 26.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Royal College of Physicians and Surgeons of Canada
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 26.25 ABIM
- 31.25 ABS
- 31.25 AMA PRA Category 1 Credit™
- 31.25 Attendance
Price
Please update your profile to let us know if you have dietary restrictions or access requirements.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.